Ep. 5: Paul Bleicher, Phase Forward — Revolutionizing clinical trials & biotech innovation Petri Podcast

A constant innovator in patient data and healthcare, Paul Bleicher reflects on Phase Forward’s modernization of clinical trials and offers advice for “crossing the chasm” to tech adoption with risk-averse communities. Phase Forward went public and was later acquired by Oracle, and Paul went on to become the CMO of Humedica (acq Optum), and the CEO of OptumLabs. As a serial entrepreneur, Paul offers insights on the stages of early startup and on humbly knowing your own strengths - even if it means stepping aside as CEO to help your company crush it.